フィゾスチグミン

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Danger

• 危険有害性情報

  H300：飲み込むと生命に危険

  H330：吸入すると生命に危険

• 注意書き

  P260：粉じん/煙/ガス/ミスト/蒸気/スプレーを吸入しないこ と。

  P284：呼吸用保護具を着用すること。

  P304+P340：吸入した場合：空気の新鮮な場所に移し、呼吸しやすい 姿勢で休息させること。

  P320：特別な治療が緊急に必要である（このラベ ルの．．．を見よ）。

  P330：口をすすぐこと。

  P403+P233：換気の良い場所で保管すること。容器を密閉 しておくこと。

  P405：施錠して保管すること。

フィゾスチグミン 価格

フィゾスチグミン 化学特性,用途語,生産方法

• 解説

  フィソスチグミン．エセリンともいう．西アフリカに野生するマメ科Physostigma venenosumの種子カラバル豆(calabar bean)中に含まれるインドールアルカロイドの一つ．無色の板状晶．融点105～106 ℃．[α]_D－76°(クロロホルム)．水に難溶，エタノール，ベンゼン，クロロホルムに可溶．結晶も溶液も空気，日光，熱により赤色を経て暗褐色を帯びる．猛毒で延髄を麻ひさせる．コリンエステラーゼ作用を阻害してアセチルコリンを増加させ，副交感神経を興奮させる．縮瞳(どう)剤として用いられる．LD50 3 mg/kg(マウス，経口)．

• 用途

  アセチルコリンエステラーゼ阻害剤

• 効能

  アセチルコリンエステラーゼ阻害薬 (点眼薬)

• 説明

  The classic AChEI, physostigmine, is an alkaloid obtained from seeds of the Calabar bean (Physostigma venenosum). Its parasympathomimetic effects were recognized long before its structure was elucidated in 1923. In 1929, Stedman found that the mechanism of the parasympathomimetic effects of physostigmine was inhibition of AChE; it inhibits AChE by acting as a substrate and carbamylating the enzyme. Acetylcholinesterase is carbamylated at a slow rate, but physostigmine has exceptionally high affinity (Ki ~ 10-9 M) for the catalytic site of the enzyme. By comparison, the Ks for acetylcholine is on the order of 10-4 M. Thus, physostigmine is classified as a reversible AChEI that carbamylates the enzyme at a slow rate; the carbamylated AChE also is regenerated quite slowly. Because physostigmine is a tertiary amine with a pKa of 8.2 (+BH) rather than a quaternary ammonium salt, it is more lipophilic than many other AChEIs and can diffuse across the blood-brain barrier. The tertiary amine also imparts pH dependence to its ability to inhibit AChE, because its affinity for AChE is greater when the amine is protonated.

• 化学的特性

  Physostigmine is a white crystalline solid. Odorless.

• 物理的性質

  Appearance: flaky crystal. Solubility: slightly soluble in water; soluble in ethanol, benzene, and fatty oil. Melting point: 102–104 °C. Specific optical rotation: ?120° in benzene and ?76° in chloroform, respectively

• 来歴

  Eserine was first discovered as a reversible AChE inhibitor, and it is also a tertiary amine and easily crosses the blood-brain barrier. In 1846, Robert Christison observed that the extract from Calabar bean caused cardiac arrest and death; he personally ate a certain amount of the extract and felt extremely feeble but luckily survived. In 1855, Christison reported that some kind of substances in the Calabar bean possessed strong biological activity.
  In 1864, chemists afforded crystal pure extract which was named as eserine. After that, Thomas Richard Fraser and Douglas Argyll Robertson cooperated to employ eserine in experimental ophthalmology, and the results showed that the antagonistic effect of eserine on mydriasis is induced by atropine. In 1875, Ludwig Laqueur declared that eserine could also be employed to depress intraocular pressure and first used as a treatment for glaucoma. In 1925, Edgar Stedman and George Barger determined the structure of eserine, which belongs to a natural product whose structure is characterized with hexahydropyrroloindole. In 1935, Percy Lavon Julian completed the chemical synthesis of its racemate for the first time .

• 使用

  Physostigmine base (Eserine-Base) is used as bulk pharmaceuticals (parasympathomimetic, cholinergic, ophthalmic, anti-Alzheimer). Product Data Sheet

• 使用

  Because of its ability to diffuse into the CNS, it is used as an antidote for toxic concentrations in the organism of drugs with anticholinergic properties such as atropine, antihistamines, phenothiazines, and tricyclic antidepressants. Its action on the organism is basically similar to that of acetylcholine, and it is used for the same indications in ophthalmology for constricting the pupil and lowering ocular pressure in glaucoma.

• 一般的な説明

  Physostigmine is an alkaloidobtained from the dried ripe seed of Physostigma venenosum.It occurs as a white, odorless, microcrystalline powderthat is slightly soluble in water and freely soluble inalcohol, chloroform, and the fixed oils. The alkaloid, asthe free base, is quite sensitive to heat, light, moisture,and bases, undergoing rapid decomposition. In solution,it is hydrolyzed to methyl carbamic acid and eseroline,neither of which inhibits AChE. Eseroline is oxidized toa red compound, rubreserine,and then further decomposedto eserine blue and eserine brown. Addition of sulfiteor ascorbic acid prevents oxidation of the phenol, eseroline,to rubreserine. Hydrolysis does take place,however, and the physostigmine is inactivated. Solutionsare most stable at pH 6 and should never be sterilizedby heat.
  Physostigmine is a relatively poor carbamylating agentof AChE and is often considered a reversible inhibitor ofthe enzyme. Its cholinesterase-inhibiting properties varywith the pH of the medium . The conjugateacid of physostigmine has a pKa of about 8, and as the pHof the solution is lowered, more is present in the protonatedform. Inhibition of cholinesterase is greater in acidmedia, suggesting that the protonated form makes a contributionto the inhibitory activity well as its carbamylationof the enzyme.

• 健康ハザード

  Super toxic. Probable oral lethal dose is less than 5 mg/kg for a 70 kg (150 lb.) person. Material is a cholinesterase inhibitor. Effects of exposure may involve the respiratory, gastrointestinal, cardiovascular and central nervous systems. Death occurs due to respiratory paralysis or impaired cardiac function. Time to death may vary from 5 minutes to 24 hours, in severely poisoned patients, depending on factors such as the dose and route. Persons with asthma and/or persons that require drugs containing choline esters are at risk.

• 火災危険

  PHYSOSTIGMINE is a slight fire hazard. When heated to decomposition PHYSOSTIGMINE emits toxic fumes of nitrogen oxides. Keep from light and heat.

• 作用機序

  Physostigmine is easily absorbed from the gastrointestinal tract and other mucous membranes. Upon entering the bloodstream, it easily permeates the blood–brain barrier. It is inactivated by cholinesterase of the plasma. Physostigmine has a minimal direct effect on cholinesterase receptors.

• 薬理学

  Eserine was first discovered as one of AChE inhibitors. AChE inhibitor is the same as ACh, which can combine with cholinesterase, while AChE inhibitor will combine more tightly with cholinesterase, which leads to slow hydrolysis, inactive enzyme, cumulative ACh, and emergent biological activities . Although eserine does not directly activate M and N receptor, it can cross the central nervous system and strongly militate the central and peripheral nervous systems .
  When locally using eserine in the eyes, the effect is similar to pilocarpine but more powerful and durable. It can activate AChR of iridis sphincter, representing that the pupil is narrowed and the intraocular pressure is depressed, which is more obvious when being used to treat glaucoma patients. When being absorbed, the effect of eserine is similar to neostigmine, which is called as M- and N-like effects, representing that smooth muscle is activated strongly. After crossing the central nervous system, eserine can inhibit the activities induced by AChE, and it is presented as “activate previously, inhibit later.” It is noted that the effect of eserine is dependent on the status of the central nervous system .

• 臨床応用

  Physostigmine was used first as a topical application inthe treatment of glaucoma. Its lipid solubility properties permitadequate absorption from ointment bases. It is used systemicallyas an antidote for atropine poisoning and otheranticholinergic drugs by increasing the duration of actionof ACh at cholinergic sites through inhibition of AChE.Physostigmine, along with other cholinomimetic drugs actingin the CNS, has been studied for use in the treatment ofAlzheimer disease. Cholinomimetics that are currentlyused or which have been recently evaluated in the treatmentof Alzheimer disease include donepezil, galantamine, metrifonate,rivastigmine, and tacrine. It is anticipated that thislist will continue to grow as the etiology of this disease becomesbetter understood.

• 安全性プロファイル

  A human poison by an unspecified route. Poison experimentally by ingestion, subcutaneous, intramuscular, intravenous, and intraperitoneal routes. Human systemic effects by ingestion: nausea, dyspnea, coma, blood pressure elevation, flaccid paralysis without anesthesia, muscle weakness. Normally administered by injection. Poisoning can occur as a result of a mistake in dosage or due to hypersensitivity of the patient withm 5 to 25 minutes after administration. Death usually results from respiratory paralysis. Experimental reproductive effects. Combustible when exposed to heat or flame. When heated to decomposition it emits toxic fumes of NOx. See also CARBAMATES.

• 合成

  Physostigmine, 1,3a,8-trimethyl-2,3,3a,8a-tetrahydropyrrolo[2,3-b]- indol-5-yl-N-methylcarbamate (13.2.7), is an alkaloid isolated from the so-called grand beans?aseeds of the poisonous African plant of the familia Physostigma venenosum. Physostigmine is made synthetically in various ways [40¨C42], one of which being from pethoxymethylaniline, which is reacted with |á-bromopropionyl bromide in the presence of aluminum chloride, giving 1,3-dimethyl-5-ethoxyindolin-2-one (13.2.1). Reacting this with chloracetonitrile in the presence of sodium ethoxide gives 1,3-dimethyl-5-ethoxy- 3-cyanomethylindolin-2-one (13.2.2). The nitrile group is reduced to an amine group, which is further methoxided, giving 1,3-dimethyl-5-ethoxy-3-(|? methylaminoethyl) indolin-2-one (13.2.3). The carbonyl group of this compound is reduced, forming an aminoalcohol (13.2.4), the dehydration of which leads to formation of 1,3a,8-trimethyl- 2,3,3a,8a-tetrahydropyrrolo[2,3b]-5-ethoxyindol (13.2.5). The ethoxy-protecting group is removed by hydrogen bromide, giving a compound with a phenol hydroxyl group (13.2.6), which is reacted with methylisocyanate, giving the desired physostigmine (13.2.7).

  

• 職業ばく露

  Physostigmine, an alkaloid, originally derived from the calabar bean (Physostigma venenosum) isa potent and reversible inhibitor of cholinesterase. Material is used as a cholinergic (anticholinesterase) agent and as a veterinary medication. Although listed as a carbamate pesticide, physostigmine is not registered for use as an agricultural chemical in the United States.

• 代謝

  Physostigmine is the tertiary amine that are rapidly absorbed from the gastrointestinal tract, as are tacrine, donepezil, and galanthamine, whereas quaternary ammonium compounds are poorly absorbed after oral administration. Nevertheless, quaternary ammonium compounds like neostigmine and pyridostigmine are orally active if larger doses are employed. Only the quaternary ammonium inhibitors do not readily enter the CNS. Because of their high lipid solubility and low molecular weight, most of the organophosphates are absorbed by all routes of administration; even percutaneous exposure can result in the absorption of sufficient drug to permit the accumulation of toxic levels of these compounds.

• 輸送方法

  UN2811 Toxic solids, organic, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials, Technical Name Required. UN1544 Alkaloids, solid, n.o.s. or Alkaloid salts, solid, n.o.s. poisonous, Hazard Class: 6.1; Labels: 6.1-Poisonous materials, Technical Name Required.

• 純化方法

  Eserine crystallises from Et2O or *C6H6 and forms an unstable low melting form m 86-87o [Harley-Mason & Jackson J Chem Soc 3651 1954, Wijnberg & Speckamp Tetrahedron 34 2399 1978]. [Beilstein 23/11 V 401.]

• 不和合性

  Light and heat.

• 廃棄物の処理

  It is not appropriate to dispose of expired or waste drugs or waste product such as lab chemicals by flushing them down the toilet or discarding them to the trash. Larger quantities shall carefully take into consideration applicable EPA, and FDA regulations. If possible return the lab chemicals to the manufacturer for proper disposal being careful to properly label and securely package the material. Alternatively, the waste lab chemicals shall be labeled, securely packaged and transported by a state licensed medical waste contractor to dispose by burial in a licensed hazardous or toxic waste landfill or incinerator. In accordance with 40CFR165, follow recommendations for the disposal of pesticides and pesticide containers. Must be disposed properly by following package label directions or by contacting your local or federal environmental control agency, or by contacting your regional EPA office.

フィゾスチグミン 上流と下流の製品情報

フィゾスチグミン 生産企業

Global(143)Suppliers

フィゾスチグミン スペクトルデータ(¹HNMR、¹³CNMR、IR1、IR2、MS)

57-47-6, フィゾスチグミン キーワード